BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 23940308)

  • 1. Differential translocation of the fatty acid transporter, FAT/CD36, and the glucose transporter, GLUT4, coordinates changes in cardiac substrate metabolism during ischemia and reperfusion.
    Heather LC; Pates KM; Atherton HJ; Cole MA; Ball DR; Evans RD; Glatz JF; Luiken JJ; Griffin JL; Clarke K
    Circ Heart Fail; 2013 Sep; 6(5):1058-66. PubMed ID: 23940308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of sarcolemmal FAT/CD36 by sulfo-N-succinimidyl oleate rapidly corrects metabolism and restores function in the diabetic heart following hypoxia/reoxygenation.
    Mansor LS; Sousa Fialho MDL; Yea G; Coumans WA; West JA; Kerr M; Carr CA; Luiken JJFP; Glatz JFC; Evans RD; Griffin JL; Tyler DJ; Clarke K; Heather LC
    Cardiovasc Res; 2017 Jun; 113(7):737-748. PubMed ID: 28419197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ischemia-induced activation of AMPK does not increase glucose uptake in glycogen-replete isolated working rat hearts.
    Omar MA; Fraser H; Clanachan AS
    Am J Physiol Heart Circ Physiol; 2008 Mar; 294(3):H1266-73. PubMed ID: 18178721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced sarcolemmal FAT/CD36 content and triacylglycerol storage in cardiac myocytes from obese zucker rats.
    Coort SL; Hasselbaink DM; Koonen DP; Willems J; Coumans WA; Chabowski A; van der Vusse GJ; Bonen A; Glatz JF; Luiken JJ
    Diabetes; 2004 Jul; 53(7):1655-63. PubMed ID: 15220187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine monophosphate-activated protein kinase activation, substrate transporter translocation, and metabolism in the contracting hyperthyroid rat heart.
    Heather LC; Cole MA; Atherton HJ; Coumans WA; Evans RD; Tyler DJ; Glatz JF; Luiken JJ; Clarke K
    Endocrinology; 2010 Jan; 151(1):422-31. PubMed ID: 19940039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium signaling recruits substrate transporters GLUT4 and CD36 to the sarcolemma without increasing cardiac substrate uptake.
    Angin Y; Schwenk RW; Nergiz-Unal R; Hoebers N; Heemskerk JW; Kuijpers MJ; Coumans WA; van Zandvoort MA; Bonen A; Neumann D; Glatz JF; Luiken JJ
    Am J Physiol Endocrinol Metab; 2014 Jul; 307(2):E225-36. PubMed ID: 24895286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcellular trafficking of the substrate transporters GLUT4 and CD36 in cardiomyocytes.
    Steinbusch LK; Schwenk RW; Ouwens DM; Diamant M; Glatz JF; Luiken JJ
    Cell Mol Life Sci; 2011 Aug; 68(15):2525-38. PubMed ID: 21547502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new leptin-mediated mechanism for stimulating fatty acid oxidation: a pivotal role for sarcolemmal FAT/CD36.
    Momken I; Chabowski A; Dirkx E; Nabben M; Jain SS; McFarlan JT; Glatz JF; Luiken JJ; Bonen A
    Biochem J; 2017 Jan; 474(1):149-162. PubMed ID: 27827305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of cardiac glucose and fatty acid uptake by endosomal pH and actin filaments.
    Steinbusch LK; Wijnen W; Schwenk RW; Coumans WA; Hoebers NT; Ouwens DM; Coumans WA; Hoebers NT; Diamant M; Bonen A; Glatz JF; Luiken JJ
    Am J Physiol Cell Physiol; 2010 Jun; 298(6):C1549-59. PubMed ID: 20375272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the distinct subcellular trafficking of CD36 and GLUT4 during the development of myocardial insulin resistance.
    Luiken JJFP; Nabben M; Neumann D; Glatz JFC
    Biochim Biophys Acta Mol Basis Dis; 2020 Jul; 1866(7):165775. PubMed ID: 32209364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac and skeletal muscle fatty acid transport and transporters and triacylglycerol and fatty acid oxidation in lean and Zucker diabetic fatty rats.
    Bonen A; Holloway GP; Tandon NN; Han XX; McFarlan J; Glatz JF; Luiken JJ
    Am J Physiol Regul Integr Comp Physiol; 2009 Oct; 297(4):R1202-12. PubMed ID: 19675275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatty acid translocase/CD36 deficiency does not energetically or functionally compromise hearts before or after ischemia.
    Kuang M; Febbraio M; Wagg C; Lopaschuk GD; Dyck JR
    Circulation; 2004 Mar; 109(12):1550-7. PubMed ID: 15023869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged AMPK activation increases the expression of fatty acid transporters in cardiac myocytes and perfused hearts.
    Chabowski A; Momken I; Coort SL; Calles-Escandon J; Tandon NN; Glatz JF; Luiken JJ; Bonen A
    Mol Cell Biochem; 2006 Aug; 288(1-2):201-12. PubMed ID: 16710744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extremely rapid increase in fatty acid transport and intramyocellular lipid accumulation but markedly delayed insulin resistance after high fat feeding in rats.
    Bonen A; Jain SS; Snook LA; Han XX; Yoshida Y; Buddo KH; Lally JS; Pask ED; Paglialunga S; Beaudoin MS; Glatz JF; Luiken JJ; Harasim E; Wright DC; Chabowski A; Holloway GP
    Diabetologia; 2015 Oct; 58(10):2381-91. PubMed ID: 26197708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased sarcolemmal glucose transporter abundance in myocardial ischemia.
    Brosius FC; Nguyen N; Egert S; Lin Z; Deeb GM; Haas F; Schwaiger M; Sun D
    Am J Cardiol; 1997 Aug; 80(3A):77A-84A. PubMed ID: 9293958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early pre-diabetic state alters adaptation of myocardial glucose metabolism during ischemia in rats.
    Morel S; Berthonneche C; Tanguy S; Toufektsian MC; Perret P; Ghezzi C; de Leiris J; Boucher F
    Mol Cell Biochem; 2005 Apr; 272(1-2):9-17. PubMed ID: 16010967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Responses of GLUT4-deficient hearts to ischemia underscore the importance of glycolysis.
    Tian R; Abel ED
    Circulation; 2001 Jun; 103(24):2961-6. PubMed ID: 11413087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase-D1 and downstream signaling mechanisms involved in GLUT4 translocation in cardiac muscle.
    Simsek Papur O; Glatz JFC; Luiken JJFP
    Biochim Biophys Acta Mol Cell Res; 2024 Aug; 1871(6):119748. PubMed ID: 38723678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An imbalance between glycolysis and glucose oxidation is a possible explanation for the detrimental effects of high levels of fatty acids during aerobic reperfusion of ischemic hearts.
    Lopaschuk GD; Wambolt RB; Barr RL
    J Pharmacol Exp Ther; 1993 Jan; 264(1):135-44. PubMed ID: 8380856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the subcellular trafficking of CD36, a major determinant of cardiac fatty acid utilization.
    Glatz JF; Nabben M; Heather LC; Bonen A; Luiken JJ
    Biochim Biophys Acta; 2016 Oct; 1861(10):1461-71. PubMed ID: 27090938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.